Life-threatening vaginal bleeding after starting rivaroxaban treatment.

Q4 Medicine

Ugeskrift for laeger Pub Date : 2024-05-27 DOI:10.61409/V01240012

Luna Fabricius Ekenberg, Line Markdanner Lindgren, Caroline Pehrson

引用次数: 0

Abstract

This is a case report of a 44-year-old premenopausal woman who was admitted to hospital due to uncontrollable and life-threatening vaginal bleeding after starting rivaroxaban treatment for atrial fibrillation. She had a medical history with menorrhagia due to an intrauterine fibroma. She did not respond sufficiently to factor X supplement or other non-surgical medical interventions. The bleeding subsided after bilateral embolization of aa. uterinae.

查看原文本刊更多论文

开始利伐沙班治疗后出现危及生命的阴道出血。

这是一份病例报告，患者是一名 44 岁的绝经前妇女，在开始利伐沙班治疗心房颤动后，因无法控制的阴道出血而入院，生命垂危。她曾因宫内纤维瘤导致月经过多。她对 X 因子补充剂或其他非手术医疗干预措施反应不佳。双侧子宫内膜瘤栓塞术后出血缓解。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Ugeskrift for laeger Medicine-Medicine (all)

CiteScore

0.20

自引率

0.00%

发文量

345

期刊介绍： The Ulster Medical Journal is an international general medical journal with contributions on all areas of medical and surgical specialties relevant to a general medical readership. It retains a focus on material relevant to the health of the Northern Ireland population. The Honorary Editor would welcome offers of papers for publication. Prospective authors are invited to read the notice to contributors.